U.S. panel backs claim Lilly diabetes drug cuts cardiac death
 

U.S. panel backs claim Lilly diabetes drug cuts cardiac death
(Reuters) - Eli Lilly & Co and Boehringer Ingelheim should be allowed to claim that their diabetes drug Jardiance cuts the risk of cardiovascular death, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...K4:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...K4:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/D_DFuJC86eA